1. Biliary Findings Assist in Predicting Enlargement of Intraductal Papillary Mucinous Neoplasms of the Pancreas 
Juntaro Matsuzaki, Hidekazu Suzuki, Shigeo Okuda, Akihiro Tanimoto, Keiko Asakura, Seiichiro Fukuhara, Sawako Okada, Kenro Hirata, Hideki Mori, Tatsuhiro Masaoka, Hajime Higuchi, Shigenari Hozawa, Sachio Kuribayashi, Toru Takebayashi, Toshifumi Hibi 
Clinical Gastroenterology and Hepatology 
Volume 11, Issue 5, Pages (May 2013)
DOI: /j.cgh
Copyright © 2013 AGA Institute Terms and Conditions

2. Figure 1
The study population. Two separate analyses were conducted in a cohort of patients who underwent MRCP in a single year (2006). In the cross-sectional study, MRCP findings and demographics were compared between patients with and without BD-IPMN in In the retrospective cohort study, baseline characteristics were compared between patients who did or did not experience the enlargement of BD-IPMN. Mix-IPMN, mixed type intraductal papillary mucinous neoplasm.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2013 AGA Institute Terms and Conditions

3. Figure 2
ROC curves illustrating optimal cutoff points of BD-IPMN diameter (A) and of CBD diameter (B) to predict the enlargement of BD-IPMN. Arrows indicate optimal cutoff points.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2013 AGA Institute Terms and Conditions

4. Figure 3
Kaplan–Meier curves of patients with enlarging BD-IPMN and HRs of the enlargement. (A) Patients with BD-IPMN were divided into 4 groups according to the number of risk factors consisting of diameter of IPMN more than 17 mm, gallbladder adenomyomatosis, and diameter of CBD less than 5.5 mm. (B) Patients with BD-IPMN were divided into 4 groups according to the size of BD-IPMN.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2013 AGA Institute Terms and Conditions